Not Released
Experience: Works
Not Used
Get This Part
Coding

Part:BBa_K613013

Designed by: Lilia Salimova   Group: iGEM11_EPF-Lausanne   (2011-09-20)
Revision as of 18:43, 21 September 2011 by Li sali (Talk | contribs) (In vitro characterization)

TetR V36F mutant

TetR with a point mutation V36F.


=In vitro characterization

EPFL2011 MITOMI WebLogo V36F.png

In vivo characterization

This TetR mutant was characterized in vivo by putting it into pSB3K1 under a constitutive promoter (J23116). This plasmid was cotransformed with J61002 harbouring RFP under pTet promoter (B0040) in DH5alpha cells. Cells were grown in a medium containing Kanamycin & Amplicillin plus different concentrations of ATC, ranging from 0 to 2000 ng/mL. OD600 absorbence and RFP fluorescence were measured every 10 minutes during 12 hours on a platereader machine.


Induction curves


Fluorescence measurements (RFUs) were normalized by OD600 values.

EPFL TetR-V36F-doseresponse.png


Dose-response curve


Fluorescence measurements (RFUs) were normalized by OD600 values. For each ATC concentration, we estimated the steady-state fluorescence expression by averaging the measurements over the last hour.

EPFL TetR-V36F-induction.png

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


[edit]
Categories
Parameters
None